Westat Awarded Contract to Continue Supporting the PATH Study



Westat is committed to continuing the trusted partnership with NIH/NIDA and FDA/CTP on the Population Assessment of Tobacco and Health (PATH) Study to understand tobacco use patterns and impacts on public health.

ROCKVILLE, Md., Feb. 21, 2024 /PRNewswire/ — The National Institutes of Health’s (NIH’s) National Institute on Drug Abuse (NIDA) and the U.S. Food and Drug Administration’s (FDA’s) Center for Tobacco Products (CTP) have announced the award of a third contract to Westat to continue to support the Population Assessment of Tobacco and Health (PATH) Study. Westat has supported the study since its inception in 2011.

Full story available on Benzinga.com


Leave a Reply

Your email address will not be published. Required fields are marked *